What is the difference between AOD-9604 and Hexarelin?

AOD-9604: AOD-9604 stimulates lipolysis and inhibits lipogenesis through mechanisms believed to be independent of the insulin-like growth factor pathway. Hexarelin: Potent synthetic GHRP; strongest GH secretagogue in its class; also activates CD36 scavenger receptor for cardioprotective effects

Is AOD-9604 FDA approved?

AOD-9604 is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Hexarelin FDA approved?

Hexarelin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is AOD-9604 administered in research settings?

In research settings, AOD-9604 is typically administered via the subcutaneous or oral routes. PeptideBase does not provide dosing or administration instructions.

How is Hexarelin administered in research settings?

In research settings, Hexarelin is typically administered via the subcutaneous route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›AOD-9604 vs Hexarelin

Peptide Comparison

AOD-9604 vs Hexarelin

Name: AOD-9604 vs Hexarelin — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are GH / IGF Axis peptides.

AOD-9604

Advanced Obesity Drug 9604

Fat LossNot EvaluatedResearch Only

Half-life: 30–60 minutes

192 providers listed

Full AOD-9604 profile →

Hexarelin

Examorelin

PerformanceNot EvaluatedResearch Only

Half-life: ~30-60 minutes

22 providers listed

Full Hexarelin profile →

Bottom line

Hexarelin carries stronger published evidence (RCT, 2 key studies) than AOD-9604 (Animal, 1); both are research compounds.

Quick Verdict

AOD-9604

Evidence

Emerging Evidence

Half-life

30–60 minutes

Hexarelin

Evidence

Early Research

Half-life

~30-60 minutes

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Hexarelin
Oral administration option	AOD-9604
Lower typical price per mg	AOD-9604
More provider options (192 vs 22)	AOD-9604

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

AOD-9604

Hexarelin

Mechanism Family

GH / IGF Axis

Half-life

30–60 minutes

~30-60 minutes

FDA Status

not evaluated

Admin Routes

subcutaneous, oral

subcutaneous

Availability

Research Only

Providers

192 listed

22 listed

Avail. Notes

HGH fragment 176-191. Drug development terminated 2007 (Phase 3 failure). FDA GRAS notice GRN 000792 for food ingredient use only — not a drug approval. No active NDA. Research chemical.

Potent hexapeptide GH secretagogue. No FDA approval anywhere. Not on FDA Category 1 or Category 2 list. WADA prohibited. More potent GH pulse than GHRP-6. Research use only.

Research Evidence

AOD-9604

PreclinicalAnimal · 1 key study · through 2001

Hexarelin

ClinicalRCT · 2 key studies · through 2001

Research Citations

AOD-9604

Animal2001 · Endocrinology

The effect of the growth hormone fragment AOD9604 on adipose tissue

Hexarelin

RCT2001 · Journal of Clinical Endocrinology and Metabolism

Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and inter…

RCT1996 · Clinical Endocrinology

The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone re…

About AOD-9604

AOD-9604 stimulates lipolysis and inhibits lipogenesis through mechanisms believed to be independent of the insulin-like growth factor pathway. It appears to mimic the fat-metabolising action of growth hormone without triggering the proliferative effects associated with full GH or GH-releasing peptides. Oral bioavailability has been observed in some formulations, making it of interest for non-injectable protocols.

Research Areas

selective fat tissue lipolysis via GH C-terminal fragment mechanismadipose metabolism stimulation without IGF-1 elevationoriginally developed to isolate GH lipolytic effect from growth effectssubcutaneous injection — reconstitution with bacteriostatic water required

About Hexarelin

Potent synthetic GHRP; strongest GH secretagogue in its class; also activates CD36 scavenger receptor for cardioprotective effects

Research Areas

potent GH secretion via GHS-R1a agonismcardiac tissue activity via CD36 receptor pathwaysmuscle recovery and lean mass supportreceptor desensitization with repeated use — cycling protocols studied

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

AOD-9604

Contraindications

Pregnant Or Nursing

Hexarelin

Contraindications

Active CancerAcromegalyHyperprolactinemia

Price (per mg)

AOD-9604

$8.10/mg

$6.11 – $13.71 range

85 vendors

View price index →Find providers →

Hexarelin

$11.47/mg

$6.58 – $14.00 range

15 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

AOD-9604

192 listed

Browse directory →

Providers offering

Hexarelin

22 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More GH / IGF Axis Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated June 29, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). AOD-9604 vs Hexarelin — Per-mg Price Comparison. Retrieved July 5, 2026, from https://peptidebase.io/peptides/compare/aod-9604/hexarelin

https://peptidebase.io/peptides/compare/aod-9604/hexarelin Methodology License Download JSON Download CSV